PMA P030031S110

Device
VISITAG SURPOINT External Processing Unit (EPU)
Applicant
Biosense Webster, Inc.
Product code
OAD
Decision date
2021-11-12
Generic name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Approval order statement
Approval for changes to the Indications for Use and the Instructions for Use (IFU) for the VISITAG SURPOINT External Processing Unit (EPU).

Current openFDA PMA Record#

Device
VISITAG SURPOINT External Processing Unit (EPU)
Applicant
Biosense Webster, Inc.
PMA number
P030031
Supplement
S110
Product code
OAD
Generic name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Decision date
2021-11-12
Decision code
APPR
Date received
2020-11-20
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for changes to the Indications for Use and the Instructions for Use (IFU) for the VISITAG SURPOINT External Processing Unit (EPU).